ALHC
Alignment Healthcare IncHenter pris…
Værdiansættelse (TTM)
Kursudvikling
Kun 86 handelsdage i databasen. Viser al tilgængelig historik.
Data-readiness
10 års prishistorik er idealet for høj confidence.
- Prishistorik
- 0,3 år
- Pris-dage
- 70
- Årsregnskaber
- 7
- Peers
- 0/0
- Valuation
- 5/6
- Fundamentals
- 7/8
- Datovindue
- 2026-02-17 til 2026-05-27
Blokkere
- Raw confidence is below the 0.95 high-confidence guardrail.
Mangler før højere confidence
- Mangler ca. 9,7 års prishistorik før ideal/full.
- Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
- Kør compute-multiples for manglende valuation metrics.
- Kør fetch-fundamentals-bulk/API fallback for manglende regnskabsmetrics.
Seneste assessment
ALHC vurderet 2026-06-10
Raw confidence is below the 0.95 high-confidence guardrail.
Stores exit-aware fields without issuing sell scores yet.
Current drawdown: Future exit logic can use drawdown from recent high.
Trend break: Future exit logic can use moving-average trend breaks.
Compares price paid with earnings, cash-generation proxies and sales.
P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.
Earnings yield: Earnings yield is the inverse P/E lens.
Checks trend, momentum and current damage from recent highs.
6M momentum: Positive medium-term momentum confirms sponsorship.
Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.
Checks whether the assessment has enough recent price, fundamental and valuation data.
Price history depth: More than one trading year gives the technical pillar enough context.
Latest price freshness: Latest live or EOD price should be recent.
Treats macro as context, not a standalone trading instruction.
VIX: Normal volatility is supportive; panic or complacency is less clean.
10Y-2Y curve: Positive yield curve lowers recession stress.
Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.
Revenue growth 3Y: Sustained top-line growth supports durable compounding.
Gross margin: High gross margin gives room for reinvestment and downturns.
Adds relative context when sector peers have comparable data.
Peer count: Peer context is only scored when comparable data exists.
P/E vs peers: Own P/E 177 vs peer median 12.6; premium is treated as a possible quality premium because growth and margins are clearly better than peers.
Insider activity
| Dato | Person | Rolle | Type | Antal | Værdi | Kilde |
|---|---|---|---|---|---|---|
| 18.6.2026 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | ▼ SALG | -25.000 | -550.000 USD | sec |
| 15.6.2026 | Maroney Dawn Christine | President | ▼ SALG | -30.000 | -586.425 USD | sec |
| 12.6.2026 | Kim Hyong | Chief Medical Officer | ▼ SALG | -35.951 | -713.947 USD | sec |
| 11.6.2026 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | ▼ SALG | -25.000 | -525.000 USD | sec |
| 10.6.2026 | KAO JOHN E | Chief Executive Officer | ▼ SALG | -74.936 | -1.472.350 USD | sec |
| 3.6.2026 | Kent Mark D. | President - MSO | · ANDET | 87.719 | — | sec |
| 3.6.2026 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | · ANDET | 122.807 | — | sec |
| 2.6.2026 | Kent Mark D. | President - MSO | ▲ KØB | 14.848 | 197.627 USD | sec |
| 18.5.2026 | Maroney Dawn Christine | President | ◇ GAVE | -20.000 | — | sec |
| 15.5.2026 | Maroney Dawn Christine | President | ◇ GAVE | -1.500 | — | sec |
| 15.5.2026 | Maroney Dawn Christine | President | ▼ SALG | -30.000 | -482.565 USD | sec |
| 11.5.2026 | KAO JOHN E | Chief Executive Officer | ▼ SALG | -280.893 | -4.732.879 USD | sec |
Earnings
| Quarter | Date | EPS actual | EPS est | EPS surprise | Revenue surprise | |
|---|---|---|---|---|---|---|
| 2026Q1 | 30.4.2026 | 0,12 | 0,09 | +38.7% | +38.7% | Beat |
| 2025Q4 | 30.1.2026 | -0,00 | -0,08 | +98.2% | +98.2% | Beat |
| 2025Q3 | 30.10.2025 | 0,10 | -0,01 | +1081.0% | +1081.0% | Beat |
| 2025Q2 | 30.7.2025 | 0,14 | 0,01 | +1005.6% | +1005.6% | Beat |